NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 04:00PM ET
1.57
Dollar change
-0.09
Percentage change
-5.42
%
IndexRUT P/E- EPS (ttm)-1.45 Insider Own13.11% Shs Outstand48.20M Perf Week9.03%
Market Cap75.84M Forward P/E- EPS next Y- Insider Trans-1.03% Shs Float41.98M Perf Month-10.29%
Income-24.34M PEG- EPS next Q- Inst Own36.15% Short Float26.42% Perf Quarter-37.70%
Sales0.00M P/S- EPS this Y62.33% Inst Trans22.59% Short Ratio6.69 Perf Half Y-94.48%
Book/sh3.02 P/B0.52 EPS next Y- ROA-15.75% Short Interest11.09M Perf Year-92.36%
Cash/sh2.66 P/C0.59 EPS next 5Y- ROE-17.19% 52W Range1.15 - 42.20 Perf YTD-33.47%
Dividend Est.- P/FCF- EPS past 5Y-40.61% ROI-16.71% 52W High-96.28% Beta-2.31
Dividend TTM- Quick Ratio11.62 Sales past 5Y0.00% Gross Margin- 52W Low36.52% ATR (14)0.16
Dividend Ex-DateDec 13, 2012 Current Ratio11.62 EPS Y/Y TTM81.00% Oper. Margin- RSI (14)44.16 Volatility9.06% 9.69%
Employees30 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price2.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-15.73% Payout- Rel Volume0.49 Prev Close1.66
Sales Surprise- EPS Surprise2.28% Sales Q/Q- EarningsMar 03 BMO Avg Volume1.66M Price1.57
SMA2011.23% SMA50-25.11% SMA200-88.40% Trades Volume807,002 Change-5.42%
Date Action Analyst Rating Change Price Target Change
Nov-26-24Downgrade H.C. Wainwright Buy → Neutral
Oct-08-24Upgrade H.C. Wainwright Neutral → Buy $116
Jul-01-24Downgrade H.C. Wainwright Buy → Neutral
Nov-16-22Downgrade B. Riley Securities Buy → Neutral $44
Jul-15-21Downgrade Cantor Fitzgerald Overweight → Neutral $100
Jul-07-21Reiterated Maxim Group Buy $80 → $190
Apr-27-21Initiated B. Riley Securities Buy $78
Feb-16-21Reiterated H.C. Wainwright Buy $20 → $66
Oct-23-20Initiated Cantor Fitzgerald Overweight $24
Sep-23-20Upgrade H.C. Wainwright Neutral → Buy $20
Apr-21-25 04:30PM
Apr-01-25 09:35AM
Mar-31-25 10:00AM
Mar-26-25 10:02AM
07:43AM
08:05AM Loading…
Mar-25-25 08:05AM
Mar-20-25 06:18PM
Mar-05-25 11:20AM
Mar-03-25 07:30AM
Feb-27-25 07:00AM
Jan-16-25 01:56PM
Jan-13-25 12:15PM
Jan-07-25 04:30PM
Dec-27-24 05:45AM
Dec-16-24 02:55PM
04:15PM Loading…
Nov-25-24 04:15PM
03:57PM
09:19AM
07:30AM
Nov-24-24 08:01PM
Nov-18-24 08:30AM
Nov-07-24 07:55AM
Oct-31-24 08:30AM
Oct-17-24 09:19PM
Oct-09-24 08:29AM
Sep-27-24 03:36PM
10:10AM
Sep-26-24 06:15PM
Sep-24-24 08:30AM
Sep-09-24 08:30AM
08:31AM Loading…
Sep-03-24 08:31AM
Aug-17-24 10:44PM
08:22AM
Aug-08-24 08:00AM
Aug-06-24 10:00AM
Aug-05-24 09:01AM
Aug-01-24 08:30AM
Jul-30-24 08:15AM
Jul-17-24 12:26PM
08:00AM
Jul-08-24 04:45PM
Jul-05-24 07:30AM
Jul-04-24 07:47AM
Jul-01-24 03:54PM
01:30PM
11:20AM
10:40AM
Jun-28-24 06:14PM
03:58PM
Jun-27-24 03:38PM
May-23-24 09:55AM
May-10-24 08:53PM
04:02PM
May-08-24 11:00AM
May-01-24 09:10AM
Apr-30-24 01:16PM
Apr-15-24 09:20AM
Mar-25-24 09:13AM
Mar-13-24 10:45AM
Mar-04-24 09:15AM
Feb-28-24 09:14AM
Feb-23-24 11:30AM
Feb-08-24 10:39AM
Feb-07-24 09:08AM
Feb-05-24 02:35PM
Jan-05-24 11:46AM
09:12AM
Dec-26-23 05:06AM
Dec-15-23 06:06PM
Dec-13-23 11:10AM
Dec-12-23 02:02PM
09:13AM
Dec-08-23 07:31PM
Dec-07-23 04:01PM
Nov-14-23 09:53PM
Nov-07-23 09:39AM
09:01AM
Nov-06-23 09:15AM
Oct-31-23 08:15AM
Oct-25-23 09:15AM
Oct-19-23 09:59AM
Oct-16-23 07:01PM
05:26PM
Oct-13-23 03:29PM
03:29PM
12:45PM
11:21AM
Oct-12-23 11:43PM
Oct-06-23 03:13PM
Oct-05-23 09:15AM
Oct-02-23 09:00AM
Sep-18-23 09:15AM
Sep-14-23 06:30AM
Sep-13-23 05:20PM
Sep-11-23 09:10AM
Sep-06-23 09:15AM
Aug-29-23 07:30AM
Aug-03-23 09:07AM
Jul-29-23 11:30AM
Jul-13-23 07:31AM
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kupiec James WilliamChief Medical OfficerNov 29 '24Sale3.874,00015,4800Dec 03 04:18 PM
Schoen EricChief Financial OfficerNov 29 '24Option Exercise1.1850,00059,00071,300Dec 03 04:16 PM
Schoen EricChief Financial OfficerNov 29 '24Sale3.8659,800230,82811,500Dec 03 04:16 PM
Schoen EricChief Financial OfficerNov 29 '24Sale3.822,0007,6400Dec 03 04:16 PM
Schoen, Eric J. (SAVA)OfficerNov 29 '24Proposed Sale3.822,0007,640Dec 02 05:14 PM
Schoen EricOfficerNov 29 '24Proposed Sale3.8659,800230,966Nov 29 03:33 PM